Pomdoctor Limited - Class A (POM) closed at $1.54 on October 30, 2026, down 22.6% from the previous close, on volume of 561,435 shares (30-day average 4,093,634).
Data as of October 30, 2026.
PRNewswire (Mon, 19-Oct 8:31 AM ET)
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
PRNewswire (Mon, 12-Oct 8:00 AM ET)
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
PRNewswire (Fri, 9-Oct 4:06 PM ET)
POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
PRNewswire (Wed, 30-Sep 8:01 AM ET)
PRNewswire (Thu, 24-Sep 8:01 AM ET)
POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
PRNewswire (Thu, 10-Sep 8:00 AM ET)
POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy
PRNewswire (Thu, 27-Aug 8:01 AM ET)
POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine
PRNewswire (Mon, 10-Aug 8:00 AM ET)
POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure
PRNewswire (Mon, 3-Aug 8:00 AM ET)
Pomdoctor’s Online Hospital Revenue Jumps 82%—Margin Pressures Remain Despite IPO Success
Market Chameleon (Thu, 4-Dec 6:50 AM ET)
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.
Pomdoctor Limited - Class A trades on the NASDAQ stock market under the symbol POM.
As of October 30, 2026, POM stock price declined to $1.54 with 561,435 million shares trading.
POM has a beta of 2.99, meaning it tends to be more sensitive to market movements. POM has a correlation of 0.01 to the broad based SPY ETF.
POM has a market cap of $4.28 million. This is considered a Sub-Micro Cap stock.
POM has underperformed the market in the last year with a price return of -99.8% while the SPY ETF gained +12.3%. POM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -73.4% and -75.6%, respectively, while the SPY returned +2.1% and -1.0%, respectively.
POM support price is $1.57 and resistance is $2.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that POM shares will trade within this expected range on the day.
